System
Requirements----Sponsors----Privacy
Statement----Contact
Information
|
1. Of the 1.3 million people diagnosed with
cancer in 2002, what percentage will survive at
least five years after diagnosis? help
|
2. Estimates of the frequency of pain,
depression and fatigue in cancer patients are
well established.help
|
3. The most common clinical assessment for
pain, depression and fatigue is: help
|
4. Which of the following patient
characteristics should be considered as possibly
affecting presentation and treatment of
symptoms? help
|
5. Asking patients about pain severity and
impairment due to pain may be feasible and
useful for recommending treatments for pain.
help
|
6. Which of the following are types of
instruments are most commonly used for assessing
depression? help
|
7. The common-sense WHO three-step analgesic
ladder is: help
|
8. Randomized controlled trials of
antidepressants have shown benefit when used at
an adequate dose and duration. help
|
9. Convincing evidence for effective
treatment of fatigue exists for which of the
following: help
|
10. Provider barriers to effective management
include all but which of the following:
help
|
11. Which of the following are barriers to
effective pain management that affect patients
and families: help
|
12. System barrier to effective pain
management include all but the following:
help
|
13. Lack of recognition of depression and
inadequate resources for treatment is a serious
impediment to management. help
|
14. Serious barriers to management of fatigue
include all but which of the following:
help
|
15. Strategies for improving symptom
management involve: help
|
16. Strategies for alleviating system
barriers include: help
|
17. All patients should have access to
adequate and timely pain control. help
|
18. Education and awareness of the need for
adequate pain management: help
|
19. Triplicate prescriptions have been shown
to efficaciously reduce fraud. help
|
Your response to the following
questions, while greatly appreciated,
is optional and will have no effecton
the test score
Rating of
Objectives and Program
|
Please rate the attainment of
objectives.
Upon completion of this CME activity
how well did you feel you can describe
the issues related to the following
conference questions:
|
a) What is the occurrence of pain,
depression, and fatigue, alone and in
combination, in people with cancer?
|
|
b) What are the methods used for
clinical assessment of these symptoms
throughout the course of cancer, and
what is the evidence for their
reliability and validity in cancer
patients?
|
|
c)What are the treatments for
cancer-related pain, depression, and
fatigue, and what is the evidence for
their effectiveness?
|
|
d) What are the impediments to
effective symptom management in people
diagnosed with cancer, and what are
optimal strategies to overcome these
impediments?
|
|
The overall
quality of the
instructional process was an
asset to this CME program
|
|
To what extent will participation in
this CME activity enhance your
professional
effectiveness?
|
|
Did you perceive any commercial
bias;
|
|
If yes, please explain:
|
|
What comments or suggstions do you
have for the faculty (statement
authors)?
|
|
What will you do differently as a
result of this educational
activity?
|
|
Are there new topics you would like
covered in this activity or in a
related activity?
|
|
Do you have additional comments to
enhance the utility or impact of the
activity?
|
|
Office
of Medical Applications of
Research
6100 Executive Blvd. Room 2B03
Bethesda, MD 20892
Phone: 301-496-1144
Fax: 301-402-0420
|
|